InsiderClue
Insiders · Profile

Berkman Charles S

Chief Legal Officer at OmniAb · SVP, Gen. Counsel & Secretary at LIGAND PHARMACEUTICALS. Filing since 16 Feb 2011. CIK 0001392266

OABI OmniAb, Inc. Chief Legal Officer · 10 trades LGND LIGAND PHARMACEUTICALS INC SVP, Gen. Counsel & Secretary · 20 trades
Company
Date
Role
Action
Shares
Amount
Of holding
OABI OmniAb, Inc.
7 Apr 2026
Chief Legal Officer
Sold at will
7,157
$10.66K
1.8%
OABI OmniAb, Inc.
18 Feb 2026
Chief Legal Officer
Sold at will
9,673
$16.54K
2.4%
OABI OmniAb, Inc.
17 Feb 2026
Chief Legal Officer
Sold at will
6,990
$11.88K
1.8%
OABI OmniAb, Inc.
8 Dec 2025
Chief Legal Officer
Sold at will
8,044
$15.77K
2.1%
OABI OmniAb, Inc.
7 Apr 2025
Chief Legal Officer
Sold at will
7,206
$14.41K
1.9%
OABI OmniAb, Inc.
19 Feb 2025
Chief Legal Officer
Sold at will
7,255
$26.63K
2.0%
OABI OmniAb, Inc.
18 Feb 2025
Chief Legal Officer
Sold at will
8,215
$30.23K
2.2%
OABI OmniAb, Inc.
21 Jan 2025
Chief Legal Officer
Sold at will
25,489
$82.58K
6.9%
OABI OmniAb, Inc.
9 Dec 2024
Chief Legal Officer
Sold at will
8,022
$33.13K
2.4%
OABI OmniAb, Inc.
8 Apr 2024
Chief Legal Officer
Sold at will
6,954
$36.65K
2.3%
LGND LIGAND PHARMACEUTICALS INC
4 Feb 2021
SVP, Gen. Counsel & Secretary
Sold, plan not stated
18,097
$3.23M
38.5%
LGND LIGAND PHARMACEUTICALS INC
4 Jun 2020
SVP, Gen. Counsel & Secretary
Sold, plan not stated
11,146
$1.32M
21.4%
LGND LIGAND PHARMACEUTICALS INC
17 Sep 2018
SVP, Gen. Counsel & Secretary
Sold, plan not stated
2,813
$705.18K
9.2%
LGND LIGAND PHARMACEUTICALS INC
4 Sep 2018
SVP, Gen. Counsel & Secretary
Sold, plan not stated
19,417
$4.95M
41.2%
LGND LIGAND PHARMACEUTICALS INC
9 Aug 2017
VP, Gen. Counsel & Secretary
Sold, plan not stated
18,625
$2.36M
43.3%
LGND LIGAND PHARMACEUTICALS INC
5 Aug 2016
VP, Gen. Counsel & Secretary
Sold, plan not stated
22,067
$2.72M
42.7%
LGND LIGAND PHARMACEUTICALS INC
10 Jul 2015
VP, Gen. Counsel & Secretary
Sold, plan not stated
14,067
$1.39M
34.7%
LGND LIGAND PHARMACEUTICALS INC
16 Mar 2015
VP, Gen. Counsel & Secretary
Sold, plan not stated
11,264
$839.65K
30.2%
LGND LIGAND PHARMACEUTICALS INC
31 Dec 2014
VP, Gen. Counsel & Secretary
Bought
126
$5.70K
0.5%
LGND LIGAND PHARMACEUTICALS INC
30 Jun 2014
VP, Gen. Counsel & Secretary
Bought
329
$14.41K
1.2%
LGND LIGAND PHARMACEUTICALS INC
27 May 2014
VP, Gen. Counsel & Secretary
Sold, plan not stated
7,166
$479.43K
21.0%
LGND LIGAND PHARMACEUTICALS INC
12 Feb 2014
VP, Gen. Counsel & Secretary
Sold, plan not stated
14,881
$1.11M
34.8%
LGND LIGAND PHARMACEUTICALS INC
31 Dec 2013
VP, Gen. Counsel & Secretary
Bought
209
$7.09K
0.8%
LGND LIGAND PHARMACEUTICALS INC
30 Aug 2013
VP, Gen. Counsel & Secretary
Sold, plan not stated
28,323
$1.35M
61.2%
LGND LIGAND PHARMACEUTICALS INC
16 Aug 2013
VP, Gen. Counsel & Secretary
Sold, plan not stated
14,583
$621.73K
51.7%
LGND LIGAND PHARMACEUTICALS INC
28 Jun 2013
VP, Gen. Counsel & Secretary
Bought
815
$14.15K
6.4%
LGND LIGAND PHARMACEUTICALS INC
10 May 2013
VP, Gen. Counsel & Secretary
Sold, plan not stated
4,000
$106.64K
23.8%
LGND LIGAND PHARMACEUTICALS INC
7 Sep 2012
VP, Gen. Counsel & Secretary
Sold, plan not stated
4,249
$79.75K
22.9%
LGND LIGAND PHARMACEUTICALS INC
8 Mar 2012
VP, Gen. Counsel & Secretary
Sold, plan not stated
3,606
$56.83K
17.2%
LGND LIGAND PHARMACEUTICALS INC
16 Feb 2011
VP, Gen. Counsel & Secretary
Sold, plan not stated
5,000
$48.75K
29.9%
30 decisions on file.